Massachusetts Financial Services
OLMA icon

Massachusetts Financial Services’s Olema Pharmaceuticals OLMA Stock Holding History

Massachusetts Financial Services’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Sell
45,211
-1,801
-4% -$24.1K ﹤0.01% 943
2026
Q1 		$701K Buy
+47,012
New +$1.05M ﹤0.01% 868

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Massachusetts Financial Services's OLMA Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Olema Pharmaceuticals (OLMA) stake by 3.8% in Q2 2026, selling an estimated $24.1K and leaving 45,211 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Massachusetts Financial Services first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $701K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Massachusetts Financial Services held 45,211 shares of Olema Pharmaceuticals worth $566K as of Q2 2026.
  • Massachusetts Financial Services sold 1,801 Olema Pharmaceuticals shares in Q2 2026, an estimated $24.1K.
  • Olema Pharmaceuticals made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #943 holding.
  • Massachusetts Financial Services first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Massachusetts Financial Services's Olema Pharmaceuticals position peaked at $701K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.